FDA Issues New Safety Alert on Reumofan

The Food and Drug Administration (FDA) issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

The FDA says it has received dozens of additional adverse event reports of bleeding, stroke, liver damage and death among users of Reumofan Plus and Reumofan Plus Premium. The agency says the dietary supplements contain several potentially harmful active pharmaceutical ingredients that are not listed on the product labels including:

- Dexamethasone, a corticosteroid drug that can impair the body’s ability to fight infections and cause high blood sugar levels

- Diclofenac sodium, an NSAID drug that may cause increased risk of heart attack and stroke

- Methocarbamol a muscle relaxant that can cause sedation, dizziness and low blood pressure, among other side effects

The FDA issued its first warning about the product on June 1, 2012. It says other reports of serious injury include sudden worsening of glucose control, weight gain, swelling, leg cramps and withdrawal syndrome, and adrenal suppression.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you. For legal help, call (800) 581-6358.

Tags: